Mona P. Rosenberg

Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision

Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis et al. · Clinical Cancer Research · 2009 · 416 citations · Full text

Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.

Cheryl A. London, Alison L. Hannah, Regina Zadovoskaya et al. · PubMed · 2003 · 288 citations

Chemoprevention Strategy, Kinase Inhibitors, Pathology +16

Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study

Cheryl A. London, Heather L. Gardner, Tamra Mathie et al. · PLoS ONE · 2015 · 77 citations · Full text

Retrospective Evaluation of Adjunctive Doxorubicin for the Treatment of Feline Mammary Gland Adenocarcinoma: 67 Cases

C. Andrew Novosad, Philip J. Bergman, Maura G. O’Brien et al. · Journal of the American Animal Hospital Association · 2006 · 77 citations

Survival Time, Surgical Oncology, Medical Records +12

Prognostic Factors in Dogs with Lymphoma and Associated Hypercalcemia

Mona P. Rosenberg, Robert E. Matus, Amiya K. Patnaik · Journal of Veterinary Internal Medicine · 1991 · 49 citations · Full text

Animal Physiology, Prognostic Factors, Medicine +13